Royal Philips has introduced DeviceGuide, an AI-powered solution designed to assist doctors during minimally invasive heart valve repair procedures. The technology, unveiled on November 17, 2025, uses artificial intelligence to track and visualize small repair devices in real time as they move through the beating heart, providing clinicians with enhanced 3D guidance during complex interventions. DeviceGuide is built on Philips’ EchoNavigator platform and is specifically designed for mitral transcatheter edge-to-edge repair (M-TEER), a procedure used to treat mitral valve regurgitation—a condition affecting over 35 million adults worldwide. This condition causes blood to leak backward through the heart’s mitral valve, leading to symptoms like shortness of breath, fatigue, and reduced quality of life. For patients who are too frail for open-heart surgery, M-TEER offers a life-changing alternative, performed through a small incision in the groin. During the procedure, physicians guide flexible instruments and a repair device through blood vessels into the heart, requiring precise navigation in real time. Traditionally, doctors rely on multiple screens showing X-ray and ultrasound images, coordinated between two operators, while making split-second decisions. This process is highly demanding and requires significant experience. DeviceGuide addresses these challenges by using an AI algorithm to automatically track the repair device as it moves through the heart. The system fuses live echo and X-ray data to generate a real-time 3D model of the device, superimposed on the patient’s anatomy. This provides a clear, intuitive view of the device’s position and orientation, helping doctors guide it more accurately to seal the leak. Dr. Atul Gupta, Chief Medical Officer, Diagnosis & Treatment at Philips, described the technology as a “bionic vision” tool that enhances, rather than replaces, clinical expertise. “The AI software serves as an assistive tool, with the physician always remaining in control,” he said. “It gives doctors an extra pair of eyes, helping them treat more patients safely and confidently.” The innovation was developed in collaboration with Edwards Lifesciences, the manufacturer of the repair devices used in M-TEER. The partnership combines Philips’ strengths in medical imaging and AI with Edwards’ leadership in structural heart therapies. Together, they have reimagined key steps in the procedural workflow to improve precision and efficiency. Mark Stoffels, Business Leader at Philips’ Image Guided Therapy Systems, emphasized that DeviceGuide exemplifies a new model for innovation—where imaging and therapy expertise are integrated to create AI-enabled solutions tailored to real-world clinical needs. DeviceGuide will be showcased at London Valves 2025, one of the world’s premier conferences for structural heart specialists. The solution highlights Philips’ ongoing commitment to advancing AI-driven, image-guided interventions that improve outcomes for patients and support clinicians in high-pressure environments.